Targeting replication stress in triple-negative breast cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210099
- Recipient
-
Yale Univ UEI FL6GV84CKN57
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $753,749
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- New Haven, CT 06511, USA
Award details come from USAspending.gov.
About this award
The Yale University was awarded a $753,749 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2022 through March 2025 to target replication stress in triple-negative breast cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative research and investigating medical solutions for battlefield medicine. Yale University will leverage this funding to advance scientific understanding and develop potential treatments for an aggressive form of breast cancer that disproportionately impacts younger women.
Quick answers
Who received award W81XWH2210099?
W81XWH2210099 was awarded to Yale Univ by Medical Command (Department of the Army) on March 15, 2022.
How much is award W81XWH2210099 worth?
$753,749 has been obligated on W81XWH2210099.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award